Becton Dickinson and : BD Ranks First in its Industry in America’s Best Large Employers List
February 22, 2022 at 03:53 pm EST
Share
[Link]
FRANKLIN LAKES, N.J., Feb. 22, 2022 -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that it ranked No. 1 in the Health Care Equipment & Services industry in America's Best Large Employers List by Forbes.
The ranking takes into consideration factors including working conditions, development opportunities, compensation, and diversity, equity and inclusion.
"This ranking reflects BD's commitment to being a great place to work, and being an employee-driven survey makes the recognition even more meaningful," said Tom Polen, chairman, CEO and president of BD. "We believe in fostering an inclusive culture where associates can thrive in their careers while fulfilling our purpose of advancing the world of health."
The rankings were compiled by surveying 60,000 Americans working for businesses with at least 1,000 employees. Participants were asked to rate their willingness to recommend their own employers to friends and family, and to nominate organizations other than their own. The final list ranks the 500 large employers that received the most recommendations. BD ranked 194th overall.
Visit the company's website to learn more about its environmental, social and governance strategy and commitment to advancing company, planet, community and human health.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Contacts:
Media:
Investors:
Troy Kirkpatrick
Francesca DeMartino
VP, Public Relations
SVP, Head of Investor Relations
858.617.2361
201.847.5743
troy.kirkpatrick@bd.com
francesca.demartino@bd.com
Attachments
Original Link
Original Document
Permalink
Disclaimer
BD - Becton, Dickinson and Company published this content on 22 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 February 2022 20:52:05 UTC.
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:
- medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.;
- diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;
- clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.
Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).